SCHEMBL3432392

SCHEMBL3432392

Nc1ncc(-c2ccccc2)c(N2CC3CC2CO3)n1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAP3K12 Q12852 16/20 0.52
MTOR P42345 2/20 0.48
PIK3CA P42336 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3432395 0.81 MAP3K12 (0.52) MAP3K12
SCHEMBL21658972 0.80 MAP3K12 (0.48) MAP3K12MTORPIK3CA
SCHEMBL3433510 0.78 HRH4 (0.52) MAP3K12
SCHEMBL3430562 0.77 CHRNA7 (0.56)
SCHEMBL3431228 0.73 CHRNA7 (0.38)
SCHEMBL2577774 0.71 MAP3K12 (0.49) MAP3K12MTORPIK3CA
SCHEMBL22163205 0.69 MAP3K12 (0.51) MAP3K12MTORPIK3CA
SCHEMBL18436556 0.68 PRKDC (0.45) MAP3K12MTORPIK3CA
SCHEMBL16210488 0.68 MAP3K12 (1.00) MAP3K12
SCHEMBL7708544 0.68 NOS1 (0.58) MTORPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265607-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES Rigel Pharmaceuticals, Inc. (US) 2010-12-29 EP disclosed
WO-2009103032-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES RIGEL PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed